Clinical Trial Update: Hydralazine Valproate for Cervical Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of hydralazine and valproate for metastatic cervical cancer; current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Hydralazine (hydralazine)
• Valproate (valproate)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Metastatic Cervical Cancer | Phase 3 | Status: UNKNOWN